Presented by Alison Bond
Successful implementation and use of patient-facing digital technologies (PT) in clinical trials requires collaborative effort and input from key stakeholders including sponsors, clinical research sites, patients and technology vendors. Despite this, there is often an unequal distribution of voices during the process of PT implementation, with patients, clinical research sites and vendors failing to always be heard. The TransCelerate Patient Technology initiative set out to engage all three stakeholders to better understand successful ways of working during the implementation of PT in clinical trials. The result is the Patient Technology Toolkit, which contains guidance, considerations and best practices for utilization by sponsors, clinical research sites and vendors.
In this session from June 2020's Clinical Trials Digital Week presented by Alison Bond, Director, Global Regulatory Policy & Intelligence, Janssen, viewers will learn about the proposed approaches for utilizing patient, vendor and site input into the design and implementation of clinical trials with patient technology. Primary research from conversations with patients, sites and vendors as well as the resulting tools for industry will be shared and discussed.
